The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Bibliografske podrobnosti
Main Authors:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Format:	Journal article
Jezik:	English
Izdano:	2009

Podobne knjige/članki

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
od: Edmond Auzenne, et al.
Izdano: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
od: Wachsberger, P, et al.
Izdano: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
od: Lavinia Morosi, et al.
Izdano: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
od: Choi, S, et al.
Izdano: (2008)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
od: Martina Vescio, et al.
Izdano: (2023-07-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
od: Demuytere J, et al.
Izdano: (2024-01-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
od: Hideki Iwamoto, et al.
Izdano: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
od: Cervellini, I, et al.
Izdano: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
od: Tai, J, et al.
Izdano: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
od: Tai, J, et al.
Izdano: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
od: Nils Degrauwe, et al.
Izdano: (2012-06-01)

Selective use of vandetanib in the treatment of thyroid cancer
od: Fallahi P, et al.
Izdano: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
od: Kabir, Md Zahirul, et al.
Izdano: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
od: Abdul Qadir, MPhil, et al.
Izdano: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
od: Jade Cury-Martins, et al.
Izdano: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
od: Roberta Affatato, et al.
Izdano: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
od: Zhou, J, et al.
Izdano: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
od: Alferez, D, et al.
Izdano: (2010)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
od: Heymach, J, et al.
Izdano: (2008)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
od: Francesca Ricci, et al.
Izdano: (2017-05-01)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
od: Siemann, D, et al.
Izdano: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
od: Yuxin Shen, et al.
Izdano: (2025-03-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
od: Ai Matsui, et al.
Izdano: (2022-01-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
od: Paola De Feudis, et al.
Izdano: (2000-05-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
od: Joseph J. Caumanns, et al.
Izdano: (2025-02-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
od: T. Laragione, et al.
Izdano: (2005-01-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
od: Robert J G Cardnell, et al.
Izdano: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
od: Fallahi P, et al.
Izdano: (2019-08-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
od: Busra Demirbag Gul, et al.
Izdano: (2022-02-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
od: Carlos M. Galmarini, et al.
Izdano: (2014-01-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
od: E. A. Samishina, et al.
Izdano: (2019-06-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
od: Alberto Zambelli, et al.
Izdano: (2023-01-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
od: Hartwig Kosmehl, et al.
Izdano: (2002-12-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
od: Jr, W, et al.
Izdano: (2012)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
od: Pepe D, et al.
Izdano: (2016-05-01)

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer
od: Meijia Yu, et al.
Izdano: (2024-05-01)

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
od: Federica Guffanti, et al.
Izdano: (2024-06-01)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
od: Kumar, K, et al.
Izdano: (2013)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
od: Kumar, K, et al.
Izdano: (2013)

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
od: Xiaoyue Zeng, et al.
Izdano: (2024-05-01)